FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
Janssen Diagnostics focuses on the development and marketing of advanced molecular diagnostic and practical therapy management tools for viral diseases, including HIV and other infections, as well as other chronic diseases and oncology.
Janssen Diagnostics is a research driven biotech company and a leader in the field of HIV-1 drug resistance testing. Our products and services are aimed at enhancing antiretroviral therapy management and improving the quality of life of people living with HIV and AIDS. Janssen Diagnostics was the first company to commercially provide an HIV-1 phenotyping assay, the Antivirogram(R), and is the only company that provides the virco(R)TYPE HIV-1, an advanced, data-driven and complete drug resistance analysis system. Our commitment to develop the world’s best patient management tools is reflected in continuous research efforts applying cutting edge and innovative biotech and bioinformatics technologies.
Janssen Diagnostics uses advanced techniques in biotechnology, (pharmaco-)genomics and applied bio-informatics, combined with medical and clinical virology expertise, to develop and commercialize state of the art genotyping, phenotyping and virtual phenotyping assays for HIV-1 and other viral infections.
Our researchers are currently developing various assays for testing HIV-1 resistance to novel antiretroviral drug targets, as well as software tools for advanced and practical HIV therapy management.
Janssen Diagnostics has alliances with various partners and collaborators around the world. These include partnerships for basic research and product development, strategic relationships with HIV Resistance Core centers in Europe, Canada and Asia, and commercial alliances with various distributors worldwide (Delphic (UK), LabCorp (US), Quest (US), ARUP (US), Esoterix (US), SRA (Japan), etc.). In addition, most major pharmaceutical companies active in the field of antiretroviral drug development rely on Janssen Diagnostics for drug resistance testing in their HIV clinical trials.